Sector
HealthcareOpen
₹244Prev. Close
₹238.72Turnover(Lac.)
₹834.55Day's High
₹248.28Day's Low
₹234.8352 Week's High
₹282.852 Week's Low
₹109.25Book Value
₹54.92Face Value
₹10Mkt Cap (₹ Cr.)
2,247.47P/E
17.67EPS
13.52Divi. Yield
1.884 Aug 2023
12:00 AM
AGM
Announcement Date: 04 Aug, 2023
9 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
4 Aug 2023
12:00 AM
BookCloser
23 May 2023
12:00 AM
Dividend
Dividend Amount: 3
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 91.67 | 91.67 | 91.67 | 91.67 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 287.78 | 233.77 | 181.08 | 176.13 |
Net Worth | 379.45 | 325.44 | 272.75 | 267.8 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 613.38 | 830.76 | 748.35 | 765.71 |
yoy growth (%) | -26.16 | 11.01 | -2.26 | 1.35 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -197.71 | -213.93 | -194.01 | -190.25 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 4.28 | 48.19 | 34 | 40.81 |
Depreciation | -33.32 | -32.96 | -30.68 | -30.53 |
Tax paid | -1.96 | -4.56 | -12.9 | -14.57 |
Working capital | 22.2 | -33.19 | -0.47 | 28.16 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -26.16 | 11.01 | -2.26 | 1.35 |
Op profit growth | -53.38 | 20 | -8.64 | -0.73 |
EBIT growth | -85.9 | 26.11 | -11.94 | 5.52 |
Net profit growth | -94.66 | 106.71 | -19.59 | 7.41 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,402.15 | 91.17 | 92,133.61 | 238.8 | 0.09 | 1,894.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 930.3 | 131.53 | 90,378.13 | 241.77 | 0.16 | 610.11 | 79.02 |
Fortis Healthcare Ltd FORTIS | 493.25 | 300.21 | 37,170.36 | 68.33 | 0.2 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,195.7 | 88.77 | 31,985.94 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,254.1 | 60.4 | 25,637.06 | 158.09 | 0.32 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Jasmine Shah
Vice Chairman & Non executive
Prathap C Reddy
Non Executive Director
Suneeta Reddy
Non Executive Director
Sangita Reddy
Non Executive Director
Vineeta Rai
Independent Non Exe. Director
S Regunathan
Independent Non Exe. Director
Satnam Arora
Independent Non Exe. Director
Deepak Vaidya
Independent Non Exe. Director
Arun Rai
Independent Non Exe. Director
Vinayak Chatterjee
Independent Non Exe. Director
MADHUMITA GANGULI
Independent Non Exe. Director
Menaka Gurusswamy
Independent Non Exe. Director
Salil Singhal
Non Executive Director
Vikram Bhat
Non Executive Director
Mahesh Verma
Executive Director & MD
P Shivakumar
Independent Director
Tejpreet S Chopra
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Indraprastha Medical Corporation Ltd
Summary
Indraprastha Medical Corporation was incorporated as Public Company on 16th March, 1988. The main business of the company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000. IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex, Mahatma Gandhi Marg, New Delhi. In 1998-99, stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy.During 1999-2000, the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tie-ups with private air transport companies to transfer critical cases.A Puva UV therapy unit, for treatment of complex skin conditions, has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital, providing out door consultations and diagnostic facilities, was opened in Feb.2001, in Delhi. This clinic also functions as a referra
Read More
What is the Indraprastha Medical Corporation Ltd share price today?
The Indraprastha Medical Corporation Ltd shares price on N/A is Rs.₹244.95 today.
What is the Market Cap of Indraprastha Medical Corporation Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd is ₹2245.46 Cr. as of 23 Jul ‘24
What is the PE and PB ratio of Indraprastha Medical Corporation Ltd?
The PE and PB ratios of Indraprastha Medical Corporation Ltd is 17.67 and 4.58 as of 23 Jul ‘24
What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd?
The 52-week high/low is the highest and lowest price at which a Indraprastha Medical Corporation Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Indraprastha Medical Corporation Ltd is ₹109.57 and ₹282.45 as of 23 Jul ‘24
What is the CAGR of Indraprastha Medical Corporation Ltd?
Indraprastha Medical Corporation Ltd's CAGR for 5 Years at 46.26%, 3 Years at 41.78%, 1 Year at 107.19%, 6 Month at 41.98%, 3 Month at -2.59% and 1 Month at -5.50%.
What is the shareholding pattern of Indraprastha Medical Corporation Ltd?
The shareholding pattern of Indraprastha Medical Corporation Ltd is as follows:
Promoters - 51.00 %
Institutions - 4.85 %
Public - 44.15 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
